Table 2 Echocardiographic findings
Parameter | All patients (n = 247) | Women (n = 78) | Abnormal, n (%) | Reference, women | Men (n = 169) | Abnormal, n (%) | Reference, men |
|---|---|---|---|---|---|---|---|
Chamber sizes | |||||||
LV mass index (g/m2) | 110 (107–114) | 107 (100–113) | 45 (58) | 43–96 | 112 (108–116) | 70 (42) | 49–115 |
LV diameter index (cm/m2) | 2.7 (2.6–2.7) | 2.8 (2.7–2.9) | 16 (21) | 2.3–3.1 | 2.6 (2.5–2.7) | 21 (12) | 2.2–3.0 |
LA volume index (ml/m2) | 35 (33–37) | 35 (32–38) | 31 (47) | 16–34 | 35 (33–38) | 71 (49) | 16–34 |
RV diameter (cm) | 2.8 (2.7–2.8) | 2.7 (2.6–2.8) | 7 (10) | 1.9–3.5 | 2.8 (2.7–2.9) | 19 (13) | 1.9–3.5 |
LV and RV systolic function | |||||||
LVEF (%) | 53 (51–54) | 52 (49–54) | 41 (58) | 54–74 | 53 (52–55) | 63 (40) | 52–72 |
S’lateral LV (cm/s) | 7.7 (7.4–8.0) | 7.3 (6.8–7.8) | 17 (22) | > 5.6 | 7.9 (7.5–8.2) | 26 (16) | > 5.8 |
TAPSE (cm) | 2.2 (2.1–2.2) | 2.2 (2.1–2.3) | 13 (17) | ≥1.7 | 2.2 (2.1–2.2) | 37 (23) | ≥1.7 |
S′ RV (cm/s) | 12.7 (12.3–13.2) | 12.4 (11.8–13.1) | 15 (20) | ≥10 | 12.9 (12.3–13.5) | 32 (21) | ≥10 |
PASP (mmHg) (n = 172) | 37 (35–39) | 36 (32–39) | 17 (29) | < 40 | 37 (35–39) | 42 (37) | < 40 |
TR-gradient (mmHg) (n = 185) | 30 (28–31) | 29 (26–32) | 33 (53) | < 25 | 30 (28–32) | 77 (62) | < 25 |